Early Termination of Clinical Trials for Futility — Considerations for a Data and Safety Monitoring Board
Author:
Affiliation:
1. Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia
2. Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle
Publisher
Massachusetts Medical Society
Reference28 articles.
1. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
2. Independent Oversight of Clinical Trials through Data and Safety Monitoring Boards
3. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19
4. Monitoring for Lack of Benefit: A Critical Component of a Randomized Clinical Trial
5. An investigation of the impact of futility analysis in publicly funded trials
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Futility in Clinical Trials;JAMA;2023-08-22
2. Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma;JAMA Network Open;2023-03-31
3. The Data and Safety Monitoring Board: The Toughest Job in Clinical Trials;NEJM Evidence;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3